Is Standard BioTools Inc. (LAB) a Buy, Sell, or Hold?
Standard BioTools Inc.
NASDAQ:LAB
$0.8379 USD
-$0.01 (-1.28%)
- Volume
- 2.61M
- Average Volume
- 3.96M
- Market Capitalization
- $328.01M
- P/E Ratio
- -3.34
- Dividend Yield
- 0.00%
- Price Target
- $3.25
- Year High
- $1.72
- Year Low
- $0.70
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $12.36
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Michael Egholm |
| Industry | Medical - Equipment & Services |
| Sector | Healthcare |
| Current Symbol | LAB |
| CUSIP | 34385P108 |
| CIK | 0001162194 |
| Web | https://www.standardbio.com |
| Phone | 650 266 6000 |
| Currency | USD |
| Employees | 389 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.05 |
| Payout Ratio | 0.00 |
| Current Ratio | 12.36 |
| Quick Ratio | 11.92 |
| Cash Ratio | 6.30 |
Sales & Book Value
| Annual Sales | $85.33M |
| Price / Sales | 3.80 |
| Cash Flow | -0.24 |
| Price / Cash Flow | -3.47 |
| Price / Book | 0.58 |
Price Target and Rating
| Average Stock Price Forecast | $3.25 |
| High Stock Price Forecast | $3.25 |
| Low Stock Price Forecast | $3.25 |
| Forecast Upside/Downside | -74.22% |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 10 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.2 |
| Trailing P/E Ratio | -3.34 |
| PEG Ratio | -0.43 |
| P/E Growth | -0.43 |
| Net Income | $-74.9M |
| Net Margin | -109.08% |
| Pretax Margin | -101.82% |
| Return on Equity | -20.80% |
| Return on Assets | -14.72% |
Financials Score
| AltmanZ Score | 0.86 |
| Piotroski Score | 2.00 |
| Working Capital | 479.25M |
| Total Assets | 639.11M |
| Ebit | -87.8M |
| Market Cap | 359.52M |
| Total Liabilities | 77.99M |
Poll Results
About Standard BioTools Inc. (NASDAQ:LAB) Stock
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; ... Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
2026-06-19 12:48:57
BALA CYNWYD, Pa. , June 19, 2026 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith. com) or Marc Ackerman (mackerman@brodskysmith. com) at 855-576-4847.
LiveRamp Launches Agentic Partner Program to Fast-Track Agentic Deployments for Customers
2026-06-17 08:30:00
SAN FRANCISCO--(BUSINESS WIRE)--LiveRamp (NYSE: RAMP), the leader in data collaboration, today announced LiveRamp Agent Builders (LAB), a new program to bring more partner-built agents into its network and accelerate marketers' ability to transform planning, measurement, activation, and data transformation with AI. During LAB's pilot period, brands will have access to agents from all of the AI companies participating in the program, enabling customers to focus on finding tools that create value.
Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders?
2026-06-15 13:29:00
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
2026-06-15 11:00:00
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Standard BioTools Inc. (NASDAQ: LAB) and Treeline Biosciences, Inc. Upon closing
2026-06-15 10:11:00
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Standard BioTools Inc. (NASDAQ: LAB) and Treeline Biosciences, Inc. Upon closing of the proposed transaction, Standard BioTools shareholders are expected to own approximately 16% of the combined company. Halper Sadeh encourages Standard BioTools shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 o.
Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon's White Gold District
2026-06-11 07:00:00
TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX Venture: LAB) ("Labrador Gold" or the "Company") is pleased to announce that it will host a live investor webinar on Wednesday, June 17, 2026, at 12:00 PM PT / 3:00 PM ET, featuring President and CEO Roger Moss and moderated by Cory Fleck of the KE Report. The webinar will provide investors with an in-depth overview of the Company's recently acquired Mariposa Gold Project, including its strategic location within the Yukon's prolific White Gold District, historical exploration results, the recently approved Class 1 permit, planned 2026 exploration activities and upcoming catalysts as the Company advances this district-scale gold opportunity.
Labrador Gold Announces 2026 Exploration Plans for Pacific Ridge's White Gold Projects
2026-06-11 07:00:00
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Pacific Ridge Exploration Ltd. (TSXV: PEX) (OTCQB: PEXZF) (FSE: PQW) ("Pacific Ridge" or the "Company") is pleased to report that Labrador Gold Corp. (TSXV: LAB) ("LabGold") has announced plans for its 2026 exploration programs for the Company's Mariposa and Eureka Dome gold projects in the White Gold District, Yukon.
Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript
2026-06-08 22:28:46
Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript
Frequently Asked Questions
-
What is the current Standard BioTools Inc. (LAB) stock price?
-
Standard BioTools Inc.(NASDAQ:LAB) stock price is $0.8379 in the last trading session. During the trading session, LAB stock reached the peak price of $1.72 while $0.7 was the lowest point it dropped to. The percentage change in LAB stock occurred in the recent session was --1.28% while the dollar amount for the price change in LAB stock was -$-0.01.
-
LAB's industry and sector of operation?
-
The NASDAQ listed LAB is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector.
-
Who are the executives of LAB?
-
Anders Davas | Senior Vice President of Global Operations
Hanjoon Kim | Chief Financial Officer
Sean Mackay | Chief Business Officer & Senior Vice President
Jonathan Mickelsen | Vice President & Chief Accounting Officer
Elizabeth R. Jensen | Chief Human Resources Officer -
How many employees does LAB have?
-
Number of LAB employees currently stands at 389. LAB operates from 50 Milk Street, Boston, MA 02109, US.
-
Link for LAB official website?
-
Official Website of LAB is: https://www.standardbio.com
-
How do I contact LAB?
-
LAB could be contacted at phone #650 266 6000 and can also be accessed through its website. LAB operates from 50 Milk Street, Boston, MA 02109, US.
-
How many shares of LAB are traded daily?
-
The average number of LAB shares traded daily for last 3 months was 3.96M.
-
What is the market cap of LAB currently?
-
The market value of LAB currently stands at $328.01M with its latest stock price at $0.8379